Related Experiment Videos
Chronic hepatitis C--a study of 105 cases between 1990-2000
R L Suresh1, R Kananathan, I Merican
1Department of Medicine, Hospital Kuala Lumpur, 50586, Jalan Pahang, Kuala Lumpur.
The Medical Journal of Malaysia
|January 5, 2002
Summary
This study analyzed 105 chronic hepatitis C patients in Kuala Lumpur, finding blood transfusions as the primary transmission route. A significant portion received interferon-based therapies.
Area of Science:
- Hepatology
- Virology
- Clinical Medicine
Background:
- Chronic hepatitis C (HCV) is a significant global health concern.
- Understanding patient demographics and transmission routes is crucial for effective public health strategies.
- Gastroenterology clinics manage a substantial number of chronic HCV cases.
Purpose of the Study:
- To analyze the clinical, laboratory, and virological characteristics of chronic hepatitis C patients.
- To identify the primary risk factors and modes of transmission for HCV in the studied population.
- To describe the management and treatment approaches employed for chronic hepatitis C.
Main Methods:
- Prospective data collection from 105 consecutive chronic hepatitis C patients.
- Inclusion of patient demographics, risk factors, clinical and laboratory features, and virology screening.
- Recording of management and treatment details, including interferon monotherapy and combination therapy.
Main Results:
- Chronic hepatitis C constituted 2.1% of cases at the gastroenterology clinic.
- A male preponderance was observed across all ethnic groups (74% male, 26% female).
- Blood transfusion was the predominant transmission route (48.8%), followed by other unspecified modes.
- 35.2% of patients received treatment, including interferon monotherapy and combination therapy with ribavirin.
Conclusions:
- Blood transfusion is a major risk factor for chronic hepatitis C in this Malaysian cohort.
- Male patients are disproportionately affected by chronic hepatitis C.
- A combination of interferon and ribavirin represents a key treatment strategy for naive and non-responder patients.